Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction
Xiuqing Tian,1 Qing Wang,1 Rui Guo,2 Lingling Xu,3 Qin M Chen,4 Yinglong Hou1 1Department of Cardiology, Qianfoshan Hospital of Shandong University, Jinan City, 2Department of Physiology, Nanjing University of Chinese Medicine, Nanjing City, 3College of Medicine, Weifang Medical University, Weifang...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-09-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/effects-of-paroxetine-mediated-inhibition-of-grk2-expression-on-depres-peer-reviewed-fulltext-article-NDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849433504916439040 |
|---|---|
| author | Tian X Wang Q Guo R Xu L Chen Q Hou Y |
| author_facet | Tian X Wang Q Guo R Xu L Chen Q Hou Y |
| author_sort | Tian X |
| collection | DOAJ |
| description | Xiuqing Tian,1 Qing Wang,1 Rui Guo,2 Lingling Xu,3 Qin M Chen,4 Yinglong Hou1 1Department of Cardiology, Qianfoshan Hospital of Shandong University, Jinan City, 2Department of Physiology, Nanjing University of Chinese Medicine, Nanjing City, 3College of Medicine, Weifang Medical University, Weifang City, People’s Republic of China; 4Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA Background: Paroxetine is a selective serotonin reuptake inhibitor utilized in the treatment of depression and anxiety disorders. Recent studies have identified paroxetine as a G protein-coupled receptor kinase-2 (GRK2) inhibitor capable of reversing cardiac dysfunction and remodeling in experimental models of acute myocardial infarction (AMI). We determine the clinical importance of paroxetine on cardiac functions in patients having AMI with depression (AMID) in comparison with fluoxetine, an unrelated selective serotonin reuptake inhibitor that does not inhibit GRK2.Methods: Diagnosis of depression was based on the 17-item Hamilton Depression Scale and Self-rating Depression Scale in AMI patients after hospital admission. AMID patients were randomly assigned to paroxetine or fluoxetine for treatment of depression. Heart rate variability and cardiac function were evaluated. GRK2 protein levels were measured using peripheral lymphocytes and Western blot.Results: GRK2 expression in AMID patients was significantly higher than that in AMI patients without depression. In AMID patients, GRK2 levels were positively correlated with the 17-item Hamilton Depression Scale and the Self-rating Depression Scale scores, and negatively correlated with heart rate variability. Treatment of AMID patients with paroxetine significantly reduced the expression of GRK2, normalized the autonomic nervous system function, and improved cardiac performance. In contrast, fluoxetine normalized the autonomic nervous system but did not reduce the expression of GRK2 nor improved cardiac performance.Conclusion: This study suggests that paroxetine is effective for improving cardiac function in patients with AMID and such effect correlates with GRK2 reduction. Keywords: selective serotonin reuptake inhibitors, heart rate variability, G protein-coupled receptor kinase-2, acute myocardial infarction, depression |
| format | Article |
| id | doaj-art-71a87ef77975460bbb1dae6487bd2590 |
| institution | Kabale University |
| issn | 1178-2021 |
| language | English |
| publishDate | 2016-09-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Neuropsychiatric Disease and Treatment |
| spelling | doaj-art-71a87ef77975460bbb1dae6487bd25902025-08-20T03:27:01ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212016-09-01Volume 12Issue 12333234128891Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarctionTian X0Wang Q1Guo R2Xu L3Chen Q4Hou Y5Department of CardiologyCollege of Medicine,Department of PhysiologyDepartment of CardiologyDepartment of PharmacologyDepartment of CardiologyXiuqing Tian,1 Qing Wang,1 Rui Guo,2 Lingling Xu,3 Qin M Chen,4 Yinglong Hou1 1Department of Cardiology, Qianfoshan Hospital of Shandong University, Jinan City, 2Department of Physiology, Nanjing University of Chinese Medicine, Nanjing City, 3College of Medicine, Weifang Medical University, Weifang City, People’s Republic of China; 4Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA Background: Paroxetine is a selective serotonin reuptake inhibitor utilized in the treatment of depression and anxiety disorders. Recent studies have identified paroxetine as a G protein-coupled receptor kinase-2 (GRK2) inhibitor capable of reversing cardiac dysfunction and remodeling in experimental models of acute myocardial infarction (AMI). We determine the clinical importance of paroxetine on cardiac functions in patients having AMI with depression (AMID) in comparison with fluoxetine, an unrelated selective serotonin reuptake inhibitor that does not inhibit GRK2.Methods: Diagnosis of depression was based on the 17-item Hamilton Depression Scale and Self-rating Depression Scale in AMI patients after hospital admission. AMID patients were randomly assigned to paroxetine or fluoxetine for treatment of depression. Heart rate variability and cardiac function were evaluated. GRK2 protein levels were measured using peripheral lymphocytes and Western blot.Results: GRK2 expression in AMID patients was significantly higher than that in AMI patients without depression. In AMID patients, GRK2 levels were positively correlated with the 17-item Hamilton Depression Scale and the Self-rating Depression Scale scores, and negatively correlated with heart rate variability. Treatment of AMID patients with paroxetine significantly reduced the expression of GRK2, normalized the autonomic nervous system function, and improved cardiac performance. In contrast, fluoxetine normalized the autonomic nervous system but did not reduce the expression of GRK2 nor improved cardiac performance.Conclusion: This study suggests that paroxetine is effective for improving cardiac function in patients with AMID and such effect correlates with GRK2 reduction. Keywords: selective serotonin reuptake inhibitors, heart rate variability, G protein-coupled receptor kinase-2, acute myocardial infarction, depressionhttps://www.dovepress.com/effects-of-paroxetine-mediated-inhibition-of-grk2-expression-on-depres-peer-reviewed-fulltext-article-NDTParoxetineHeart rate variabilityG protein-coupled receptor kinase-2Acute Myocardial InfarctionDepression |
| spellingShingle | Tian X Wang Q Guo R Xu L Chen Q Hou Y Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction Neuropsychiatric Disease and Treatment Paroxetine Heart rate variability G protein-coupled receptor kinase-2 Acute Myocardial Infarction Depression |
| title | Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction |
| title_full | Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction |
| title_fullStr | Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction |
| title_full_unstemmed | Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction |
| title_short | Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction |
| title_sort | effects of paroxetine mediated inhibition of grk2 expression on depression and cardiovascular function in patients with myocardial infarction |
| topic | Paroxetine Heart rate variability G protein-coupled receptor kinase-2 Acute Myocardial Infarction Depression |
| url | https://www.dovepress.com/effects-of-paroxetine-mediated-inhibition-of-grk2-expression-on-depres-peer-reviewed-fulltext-article-NDT |
| work_keys_str_mv | AT tianx effectsofparoxetinemediatedinhibitionofgrk2expressionondepressionandcardiovascularfunctioninpatientswithmyocardialinfarction AT wangq effectsofparoxetinemediatedinhibitionofgrk2expressionondepressionandcardiovascularfunctioninpatientswithmyocardialinfarction AT guor effectsofparoxetinemediatedinhibitionofgrk2expressionondepressionandcardiovascularfunctioninpatientswithmyocardialinfarction AT xul effectsofparoxetinemediatedinhibitionofgrk2expressionondepressionandcardiovascularfunctioninpatientswithmyocardialinfarction AT chenq effectsofparoxetinemediatedinhibitionofgrk2expressionondepressionandcardiovascularfunctioninpatientswithmyocardialinfarction AT houy effectsofparoxetinemediatedinhibitionofgrk2expressionondepressionandcardiovascularfunctioninpatientswithmyocardialinfarction |